Literature DB >> 25965612

Impact of serum tenascin-C on the aortic healing process during the chronic stage of type B acute aortic dissection.

Toshihiro Nozato1, Akira Sato2, Hiroyuki Hikita1, Atsushi Takahashi1, Kyoko Imanaka-Yoshida3, Toshimichi Yoshida3, Kazutaka Aonuma4, Michiaki Hiroe5.   

Abstract

Entities:  

Keywords:  Long-term outcome; Tenascin-C; Type B aortic dissection

Mesh：

Substances：

Year:  2015        PMID： 25965612     DOI： 10.1016/j.ijcard.2015.05.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  12 in total

1.  Circulating microRNAs as an emerging biomarker for acute aortic dissection diagnosis-comparing with prior biomarkers.

Authors:  Daigo Hiraya; Akira Sato; Kazutaka Aonuma
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort.

Authors:  Barnabas Gellen; Nathalie Thorin-Trescases; Eric Thorin; Elise Gand; Philippe Sosner; Sonia Brishoual; Vincent Rigalleau; David Montaigne; Vincent Javaugue; Yann Pucheu; Philippe Gatault; Xavier Piguel; Samy Hadjadj; Pierre-Jean Saulnier
Journal:  Diabetologia       Date:  2020-02-10       Impact factor: 10.122

3.  The expression and role of tenascin C in abdominal aortic aneurysm formation and progression.

Authors:  Felix Nagel; Anne-Kristin Schaefer; Inês Fonseca Gonçalves; Eylem Acar; Andre Oszwald; Philipp Kaiser; Renate Kain; Karola Trescher; Wolf H Eilenberg; Christine Brostjan; David Santer; Attila Kiss; Bruno K Podesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

4.  Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.

Authors:  Barbara Ziffels; Johanna Ospel; Katja Grün; Dario Neri; Alexander Pfeil; Michael Fritzenwanger; Hans R Figulla; Christian Jung; Alexander Berndt; Marcus Franz
Journal:  Dis Markers       Date:  2016-08-18       Impact factor: 3.434

5.  Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.

Authors:  Marcus Franz; Katja Grün; Stefan Betge; Ilonka Rohm; Bernadin Ndongson-Dongmo; Reinhard Bauer; P Christian Schulze; Michael Lichtenauer; Iver Petersen; Dario Neri; Alexander Berndt; Christian Jung
Journal:  Oncotarget       Date:  2016-12-06

6.  Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta.

Authors:  Kyoko Imanaka-Yoshida; Ken-Ichi Matsumoto
Journal:  Ann Vasc Dis       Date:  2018-06-25

7.  Tenascin-C: an emerging prognostic biomarker in diabetes.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Siqi Li; Akira Sato
Journal:  Ann Transl Med       Date:  2020-12

8.  Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.

Authors:  Yukako Yoshikane; Yoshiaki Okuma; Tatsuki Miyamoto; Junichi Hashimoto; Ryuji Fukazawa; Taichi Kato; Atsuhito Takeda; Kenji Suda; Takeji Matsushita; Michiaki Hiroe; Kyoko Imanaka-Yoshida
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-05       Impact factor: 3.054

Review 9.  Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension.

Authors:  Wei Sun; Stephen Y Chan
Journal:  Front Med (Lausanne)       Date:  2018-07-18

10.  Genetic Deletion of Socs3 in Smooth Muscle Cells Ameliorates Aortic Dissection in Mice.

Authors:  Saki Hirakata; Hiroki Aoki; Satoko Ohno-Urabe; Michihide Nishihara; Aya Furusho; Norifumi Nishida; Sohei Ito; Makiko Hayashi; Hideo Yasukawa; Tsutomu Imaizumi; Sinichi Hiromatsu; Hiroyuki Tanaka; Yoshihiro Fukumoto
Journal:  JACC Basic Transl Sci       Date:  2020-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.